Open Access
| Issue |
BIO Web Conf.
Volume 233, 2026
9th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)
|
|
|---|---|---|
| Article Number | 01023 | |
| Number of page(s) | 11 | |
| Section | Biomedical and Health Innovations | |
| DOI | https://doi.org/10.1051/bioconf/202623301023 | |
| Published online | 23 April 2026 | |
- M. K. Hong and D. C. Ding, “Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions,” Diagnostics 2025, Vol. 15, vol. 15, no. 4, Feb. 2025, doi: 10.3390/DIAGNOSTICS15040406. [Google Scholar]
- G. Funston, W. Hamilton, G. Abel, E. J. Crosbie, B. Rous, and F. M. Walter, “The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study,” PLoS Med., vol. 17, no. 10, Oct. 2020, doi: 10.1371/JOURNAL.PMED.1003295. [Google Scholar]
- S. Bayoumy et al., “Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125,” Communications Biology 2020 3:1, vol. 3, no. 1, pp. 460-, Aug. 2020, doi: 10.1038/s42003-020-01191-x. [Google Scholar]
- B. Asci Erkocyigit, O. Ozufuklar, A. Yardim, E. Guler Celik, and S. Timur, “Biomarker Detection in Early Diagnosis of Cancer: Recent Achievements in Point-of-Care Devices Based on Paper Microfluidics,” Biosensors 2023, Vol. 13, vol. 13, no. 3, Mar. 2023, doi: 10.3390/BIOS13030387. [Google Scholar]
- P. S. Filippou and P. Dey, “Proteomic Biomarkers and Diagnostic Tools in Ovarian Cancer: Understanding Their Clinical Value and Limitations,” J. Proteome Res., vol. 24, no. 7, pp. 3137–3153, Jul. 2025, doi: 10.1021/ACS.JPROTEOME.5C00088. [Google Scholar]
- A. Abdelwahed et al., “A Rational Optimization Approach for the Development of a Multiplexed Lateral Flow Immunoassay: Detection of Nonepithelial Ovarian Cancer Markers in Human Serum,” Advanced Science, p. e23192, 2026, doi: 10.1002/ADVS.202523192 [Google Scholar]
- S. Kakkar et al., “Lateral flow assays: Progress and evolution of recent trends in point-of-care applications,” Mater. Today Bio, vol. 28, p. 101188, Oct. 2024, doi: 10.1016/J.MTBIO.2024.101188. [Google Scholar]
- D. M. Kinyua, D. M. Memeu, C. N. Mugo Mwenda, B. Della Ventura, and R. Velotta, “Advancements and Applications of Lateral Flow Assays (LFAs): A Comprehensive Review,” Sensors 2025, Vol. 25, vol. 25, no. 17, Sep. 2025, doi: 10.3390/S25175414. [Google Scholar]
- J. Pedreira-Rincon et al., “A comprehensive review of competitive lateral flow assays over the past decade,” Lab Chip, vol. 25, no. 11, pp. 2578–2608, May 2025, doi: 10.1039/D4LC01075B. [Google Scholar]
- P. Tripathi, A. Kumar, M. Sachan, S. Gupta, and S. Nara, “Aptamer-gold nanozyme based competitive lateral flow assay for rapid detection of CA125 in human serum,” Biosens. Bioelectron., vol. 165, Oct. 2020, doi: 10.1016/J.BIOS.2020.112368. [Google Scholar]
- M. Majdinasab, M. Badea, and J. L. Marty, “Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests,” Pharmaceuticals 2022, Vol. 15, vol. 15, no. 1, Jan. 2022, doi: 10.3390/PH15010090. [Google Scholar]
- M. Ekman, T. Salminen, K. Raiko, T. Soukka, K. Gidwani, and I. Martiskainen, “Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3,” Anal. Bioanal. Chem., vol. 416, no. 13, pp. 3251–3260, May 2024, doi: 10.1007/S00216-024-05275-Z. [Google Scholar]
- D. J. Scoville, T. K. B. Uhm, J. A. Shallcross, and R. J. Whelan, “Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing,” J. Nucleic Acids, vol. 2017, 2017, doi: 10.1155/2017/9879135. [Google Scholar]
- P. Tripathi, M. Sachan, and S. Nara, “Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential,” Front. Chem., vol. 8, p. 531203, May 2020, doi: 10.3389/FCHEM.2020.00400. [Google Scholar]
- D. J. Chinchilla-Cardenas et al., “Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications,” Journal of Genetic Engineering and Biotechnology, vol. 22, no. 3, Sep. 2024, doi: 10.1016/j.jgeb.2024.100400. [Google Scholar]
- J. X. Hu and S. N. Ding, “In Situ Synthesis of Highly Fluorescent, Phosphorus-Doping Carbon-Dot- Functionalized, Dendritic Silica Nanoparticles Applied for Multi-Component Lateral Flow Immunoassay,” Sensors, vol. 24, no. 1, p. 19, Jan. 2024, doi: 10.3390/S24010019/S1. [Google Scholar]
- E. Lamprou, P. M. Kalligosfyri, and D. P. Kalogianni, “Beyond Traditional Lateral Flow Assays: Enhancing Performance Through Multianalytical Strategies,” Biosensors 2025, Vol. 15, vol. 15, no. 2, Jan. 2025, doi: 10.3390/BIOS15020068. [Google Scholar]
- P. Villesen, “FaBox: an online toolbox for fasta sequences,” Mol. Ecol. Notes, vol. 7, no. 6, pp. 965–968, Nov. 2007, doi: 10.1111/J.1471-8286.2007.01821.X. [Google Scholar]
- J. Li, X. Ma, X. Li, and J. Gu, “PPAI: a web server for predicting protein-aptamer interactions,” BMC Bioinformatics 2020 21:1, vol. 21, no. 1, pp. 236-, Jun. 2020, doi: 10.1186/S12859-020-03574-7. [Google Scholar]
- Y. Yan, D. Zhang, P. Zhou, B. Li, and S. Y. Huang, “HDOCK: a web server for protein-protein and protein-DNA/RNA docking based on a hybrid strategy,” Nucleic Acids Res., vol. 45, no. W1, pp. W365–W373, Jul. 2017, doi: 10.1093/NAR/GKX407. [Google Scholar]
- T. M. K. Cheng, T. L. Blundell, and J. Fernandez-Recio, “PyDock: Electrostatics and desolvation for effective scoring of rigid-body protein-protein docking,” Proteins: Structure, Function and Genetics, vol. 68, no. 2, pp. 503–515, Aug. 2007, doi: 10.1002/PROT.21419. [Google Scholar]
- J. Kimling, M. Maier, B. Okenve, V. Kotaidis, H. Ballot, and A. Plech, “Turkevich Method for Gold Nanoparticle Synthesis Revisited,” Journal of Physical Chemistry B, vol. 110, no. 32, pp. 15700–15707, Aug. 2006, doi: 10.1021/JP061667W. [Google Scholar]
- S. Valizadeh Shahbazlou, S. Vandghanooni, B. Dabirmanesh, M. Eskandani, and S. Hasannia, “Biotinylated aptamer-based SPR biosensor for detection of CA125 antigen,” Microchemical Journal, vol. 194, p. 109276, Nov. 2023, doi: 10.1016/J.MICROC.2023.109276. [Google Scholar]
- V. R. Kumar, N. C. Kampan, N. H. Abd Aziz, C. K. Teik, M. N. Shafiee, and P. S. Menon, “Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers,” Cancers 2023, Vol. 15, vol. 15, no. 23, Nov. 2023, doi: 10.3390/CANCERS15235607. [Google Scholar]
- X. Zhang et al., “An aptamer biosensor for CA125 quantification in human serum based on upconversion luminescence resonance energy transfer,” Microchemical Journal, vol. 161, Feb. 2021, doi: 10.1016/J.MICROC.2020.105761. [Google Scholar]
- A. Mohammadinejad et al., “Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims,” Biosensors 2024, Vol. 14, vol. 14, no. 2, Jan. 2024, doi: 10.3390/BIOS14020078. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.